|
Dextran 40
(dex' tran).
Dextrans. Dextrans » Dextran 40 is derived by controlled hydrolysis and fractionation of polysaccharides elaborated by the fermentative action of certain strains of Leuconostoc mesenteroides (NRRL, B.512 F; NCTC, 10817) on a sucrose substrate. It is a glucose polymer in which the linkages between glucose units are almost entirely of the
Packaging and storage
Preserve in well-closed containers. Store at 25
Labeling
Where it is intended for use in preparing injectable dosage forms, the label states that it is sterile or must be subjected to further processing during the preparation of injectable dosage forms.
USP Reference standards
USP Dextran 40 RS
USP Dextran 4 Calibration RS
USP Dextran 10 Calibration RS
USP Dextran 40 Calibration RS
USP Dextran 70 Calibration RS
USP Dextran 250 Calibration RS
USP Dextran Vo Marker RS
USP Dextran 40 System Suitability RS
USP Endotoxin RS
Color of solution
The absorbance of a solution in water (1 in 10), measured in a 4-cm cell determined at 375 nm against a water blank, is not greater than 0.20.
Identification
B:
Prepare four Test solutions of Dextran 40 in water, in such a manner that the concentrations are accurately known and approximately evenly distributed in the range of 2% to 0.5%. Using a capillary tube viscosimeter having dimensions such that the flow time of water is not less than 100 seconds, measure the flow times of water and of the Test solution at 20
{ln[(RD)(t / t0)]} / C
in which RD is the ratio of the density of the individual Test solution to that of water; t and t0 are the flow times for the Test solution and water, respectively; and C is the concentration, in g per mL, of Dextran 40 in the Test solution. Plot the viscosity numbers of each of the Test solutions against their respective concentrations, and draw the straight line of best fit through the points and extrapolate to zero concentration: the value of the intercept is between 18 and 23 mL per g.
Specific rotation
Test solution:
20 mg per mL, heated, if necessary, on a water bath to dissolve.
Bacterial endotoxins
Safety
Inject intravenously 1.0 mL of a sterile 1 in 10 solution of 10% Dextran 40 in saline TS into each of five mice weighing 18 to 20 g. The injection period is not less than 10 seconds and not greater than 15 seconds. If there are no deaths within 72 hours, it meets the requirements of the test. If 1 or more animals die, continue the test using 10 mice weighing 20 ± 0.5 g. If all animals survive for 72 hours, the requirements of the test are met.
pH
Loss on drying
Sulfate
Heavy metals, Method II
Limit of nitrogenous impurities (where it is labeled as intended for use in the preparation of injectables)
Sulfate solution
To 1000 mL of sulfuric acid add 5 g of anhydrous cupric sulfate and 500 g of potassium sulfate. Dissolve by heating, and store at 60
Indicator
Dilute a mixture of 20 mL of a 0.1% solution of bromocresol green in alcohol and 4 mL of methyl red TS with water to 100 mL.
Procedure
Transfer 0.2 g, accurately weighed, to a micro-Kjeldahl flask. Add 4 mL of Sulfate solution. Heat until the solution exhibits a clear green color and the sides of the flask are free from carbonaceous material. Cool, and transfer the solution to a steam distillation unit. Rinse the Kjeldahl flask three times with 5 mL of water, adding the washings to the solution. Add 15 mL of 45% sodium hydroxide solution, immediately close the distillation apparatus, and commence steam distillation without delay. Receive the distillate in 1 mL of Indicator in a 100-mL flask, keeping the end of the condensing tube below the liquid surface for 5 minutes and above the liquid surface for 1 minute. Upon completion of the distillation, remove the receiving flask, and rinse the end of the condensing tube with a small quantity of water, adding the rinse to the distillate. Titrate the distillate with 0.010 N hydrochloric acid until the color changes from blue to reddish violet. Perform a blank determination, and make any necessary correction. The corrected volume of 0.010 N hydrochloric acid titrated does not exceed 0.14 mL (0.01%, as N).
Limit of alcohol and related impurities
Test solution
Dissolve without heating 5.0 g in 100 mL of water, and distill the solution, collecting the first 45 mL of the distillate. Dilute the distillate with water to 50.0 mL, and mix.
Standard solution
To 25.0 mL of the Test solution add 0.5 mL of a 2.5% (w/v) solution of n-propyl alcohol.
Chromatographic system
The gas chromatograph is equipped with a flame-ionization detector and contains a 2-mm × 1.8-m column packed with support S3. The column temperature is maintained at about 160
Procedure
Separately inject equal volumes (about 1 µL) of the Test solution, the Standard solution, and a 0.05% (w/v) solution of n-propyl alcohol and water, and measure the peak responses. After corrections for any impurities in the n-propyl alcohol solution and water, the total area of peaks from impurities in the Test solution does not exceed the area of the n-propyl alcohol solution peak.
Antigenic impurities (where it is labeled as intended for use in the preparation of injectables)
Prepare a sterile solution containing 100 mg per mL in Sodium Chloride Injection. At intervals of about 48 hours, inject three 0.5-mL doses into the peritoneal cavities of each of 6 guinea pigs. At 14 days after the first intraperitoneal injection, inject 0.20 mL intravenously into each of 3 of the guinea pigs, and at 21 days treat the other 3 guinea pigs similarly. Observe the animals for 30 minutes after each intravenous injection and again 24 hours later. The animals exhibit no evidence of anaphylactoid reactions, such as coughing, bristling of hair, or respiratory distress.
Molecular weight distribution and weight and number average molecular weights
Mobile phase
Prepare a suitable degassed and filtered solution containing 7.1 g of anhydrous sodium sulfate per L in water.
Calibration solutions
Separately dissolve USP Dextran 4 Calibration RS, USP Dextran 10 Calibration RS, USP Dextran 40 Calibration RS, USP Dextran 70 Calibration RS, and USP Dextran 250 Calibration RS in Mobile phase to obtain solutions each containing 20 mg per mL.
Marker solution
Prepare a solution in Mobile phase containing 3 mg of dextrose and 3 mg of USP Dextran Vo Marker RS per mL.
System suitability solution
Prepare a solution of USP Dextran 40 System Suitability RS in Mobile phase containing 20 mg per mL.
Test solution
Prepare a solution of Dextran 40 in Mobile phase containing 20 mg per mL.
Chromatographic system (see Chromatography
(vi
Find appropriate values of b1, b2, b3, b4, and b5, using a suitable method,* that, when substituted in the equation:
and the resulting values of Mi substituted, along with their corresponding values of yi, in the equation:
give values of weight average molecular weight, Mw , within 5% of the labeled values for each of the Calibration solutions and 180 ± 2 for dextrose. Chromatograph the System suitability solution, and record the peak responses as directed for Procedure. Calculate Mw of the total molecular weight distribution using the same method as directed for the Calibration solutions, but inserting the now known values of b1, b2, b3, b4, and b5. It is between 39,000 and 46,000.
Similarly, calculate Mw of the high-fraction dextran eluted through section n by the formula:
in which n is defined by the relations:
It is between 111,000 and 135,000.
Similarly, calculate Mw of the low-fraction dextran eluted in and after section m by the formula:
in which m is defined by:
It is between 6000 and 9000.
Procedure
Chromatograph a 50-µL volume of the Test solution, and record the peak responses. Calculate values of the weight average molecular weight, Mw , of the total molecular weight distribution of the high-fraction dextran, and of the low-fraction dextran as directed for System Suitability under Chromatography
*
The Gauss-Newton method, modified by Hartley [see D. Hartley Technometrics, 3 (1961)], and the G. Nilsson and K. Nilsson method [see G. Nilsson and K. Nilsson J. Chromat., 101, 137 (1974)] are suitable methods. A curve-fitting program capable of nonlinear regression may be used.
Auxiliary Information
Please check for your question in the FAQs before contacting USP.
USP35NF30 Page 2853
Pharmacopeial Forum: Volume No. 29(6) Page 1866
|